Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01360086 | Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction | completed | Phase 2 | 65 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | May 30, 2016 | clinicaltrials |
| NCT01130805 | A Study of Pazopanib With CAPEOX in AGC Patients | completed | Phase 2 | 66 | Samsung Medical CenterOTHER | 1 | Apr 15, 2016 | clinicaltrials |
| NCT00849615 | Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction(FLOT3) | completed | Phase 2 | 252 | Krankenhaus NordwestOTHER | 1 | Apr 6, 2016 | clinicaltrials |
| NCT00390416 | Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma | completed | Phase 2 | 48 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 14, 2016 | clinicaltrials |
| NCT00858338 | Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer | completed | Phase 2 | 28 | NYU Langone HealthOTHER | 1 | Mar 11, 2016 | clinicaltrials |
| NCT00737438 | Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma | completed | Phase 2 | 22 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT02200315 | No Antimicrobial Prophylaxis for Laparoscopic Distal Gastrectomy(KSWEET-01) | completed | Phase 2 | 98 | Korean South West East Gastric Surgery GroupOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT01653496 | Compliance to ERAS After Gastric Surgery(ERAS) | completed | Phase 2 | 168 | Chonnam National University HospitalOTHER | 1 | Feb 2, 2016 | clinicaltrials |
| NCT00982592 | Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer | completed | Phase 2 | 124 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2016 | clinicaltrials |
| NCT01260701 | Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer | completed | Phase 2 | 75 | National Cancer Institute (NCI)NIH | 2 | Jan 18, 2016 | clinicaltrials |
| NCT00515216 | Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors | completed | Phase 2 | 26 | Vanderbilt UniversityOTHER | 1 | Jan 7, 2016 | clinicaltrials |
| NCT01099527 | A Trial of RAD001/Capecitabine in Refractory Gastric Cancer | completed | Phase 1 / Phase 2 | 59 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT00857246 | Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer | completed | Phase 2 | 30 | NYU Langone HealthOTHER | 1 | Dec 7, 2015 | clinicaltrials |
| NCT00397904 | Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin | completed | Phase 2 | 16 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 25, 2015 | clinicaltrials |
| NCT01152853 | PF-00299804 Monotherapy in Patients With HER-2 Positive Advance Gastric Cancer(PF299804-AGC) | completed | Phase 2 | 28 | Seoul National University HospitalOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00011960 | Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery | completed | Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 1 | Nov 17, 2015 | clinicaltrials |
| NCT02347956 | The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer | completed | Phase 1 / Phase 2 | 19 | Yonsei UniversityOTHER | 1 | Nov 16, 2015 | clinicaltrials |
| NCT01932580 | Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma | completed | Phase 2 | 10 | McGill UniversityOTHER | 1 | Oct 27, 2015 | clinicaltrials |
| NCT01130337 | A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer | completed | Phase 2 | 36 | Hoffmann-La RocheINDUSTRY | 1 | Oct 1, 2015 | clinicaltrials |
| NCT02521649 | Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer | completed | Phase 2 | 52 | Cancer Advances Inc.INDUSTRY | 0 | Aug 13, 2015 | clinicaltrials |
| NCT02518529 | Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients | completed | Phase 2 | 41 | Cancer Advances Inc.INDUSTRY | 0 | Aug 10, 2015 | clinicaltrials |
| NCT02450032 | Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer(GC5) | completed | Phase 2 | 12 | Cancer Advances Inc.INDUSTRY | 1 | May 21, 2015 | clinicaltrials |
| NCT01136031 | Paclitaxel and Irinotecan in Advanced Gastric Cancer(TI-2ndAGC) | completed | Phase 1 / Phase 2 | 42 | Seoul National University HospitalOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT00477711 | A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer(EXTRA) | completed | Phase 2 | 41 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT00842491 | Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer | completed | Phase 2 | 45 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT01336062 | Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients | completed | Phase 1 / Phase 2 | 19 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT00718913 | Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer | completed | Phase 2 | 40 | Hellenic Oncology Research GroupOTHER | 1 | May 18, 2015 | clinicaltrials |
| NCT00130689 | Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer | completed | Phase 2 | 43 | Dana-Farber Cancer InstituteOTHER | 1 | May 14, 2015 | clinicaltrials |
| NCT02442362 | TOF Versus SOX in Metastatic Gastric Cancer | completed | Phase 2 / Phase 3 | 60 | The First People's Hospital of ChangzhouOTHER | 0 | May 13, 2015 | clinicaltrials |
| NCT00084617 | Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | May 1, 2015 | clinicaltrials |
| NCT00226811 | An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy | completed | Phase 2 | 78 | PfizerINDUSTRY | 7 | Mar 30, 2015 | clinicaltrials |
| NCT02370849 | Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma | completed | Phase 2 | 2 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 25, 2015 | clinicaltrials |
| NCT00447330 | Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma(XAGastric) | completed | Phase 2 | 60 | Duke UniversityOTHER | 1 | Feb 13, 2015 | clinicaltrials |
| NCT00673673 | FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer | completed | Phase 2 | 39 | Yale UniversityOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT01874938 | A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer | completed | Phase 2 | 15 | Eli Lilly and CompanyINDUSTRY | 2 | Jan 16, 2015 | clinicaltrials |
| NCT01614522 | A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2 | completed | Phase 2 | 24 | ASLAN PharmaceuticalsOTHER | 1 | Jan 14, 2015 | clinicaltrials |
| NCT01158287 | Sorafenib. ICORG 06-41, V4 | completed | Phase 2 | 54 | Cancer Trials IrelandNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT01531452 | The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer | completed | Phase 2 | 43 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT00374985 | Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction | completed | Phase 1 / Phase 2 | 25 | Johannes Gutenberg University MainzOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00253370 | Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Nov 24, 2014 | clinicaltrials |
| NCT01497964 | Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy(GASTANA) | completed | Phase 1 / Phase 2 | 16 | SanofiINDUSTRY | 1 | Nov 10, 2014 | clinicaltrials |
| NCT01567618 | Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer(DaeMon) | completed | Phase 2 | 39 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Nov 7, 2014 | clinicaltrials |
| NCT00343239 | Docetaxel in Locally Advanced Gastric Adenocarcinoma(NEOTAX) | completed | Phase 2 | 59 | SanofiINDUSTRY | 1 | Nov 4, 2014 | clinicaltrials |
| NCT01138904 | FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC) | completed | Phase 2 | 80 | Dong-A University HospitalOTHER | 1 | Nov 4, 2014 | clinicaltrials |
| NCT01246960 | A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer | completed | Phase 2 | 168 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 8, 2014 | clinicaltrials |
| NCT00006389 | Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer | completed | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Oct 1, 2014 | clinicaltrials |
| NCT02233712 | Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer.(GC3) | completed | Phase 2 | 33 | Cancer Advances Inc.INDUSTRY | 0 | Sep 8, 2014 | clinicaltrials |
| NCT00042510 | Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer | completed | Phase 2 | 103 | Cancer Advances Inc.INDUSTRY | 0 | Aug 28, 2014 | clinicaltrials |
| NCT00991952 | Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | May 26, 2014 | clinicaltrials |
| NCT00183911 | Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma | completed | Phase 2 | 25 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
Data updated 23 days agoSource updated May 30, 2016source: clinicaltrials